| scholarly article | Q13442814 |
| P50 | author | Jakob Lerche Hansen | Q54992089 |
| P2093 | author name string | Steen Gammeltoft | |
| Mikael Schneider | |||
| Søren P Sheikh | |||
| Arne Heydorn | |||
| Anne Louise Kjølbye | |||
| Gitte Lund Christensen | |||
| Mark Aplin | |||
| P2860 | cites work | An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior | Q24310712 |
| Transduction of receptor signals by beta-arrestins | Q28246395 | ||
| Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions | Q29547189 | ||
| Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice. | Q30476292 | ||
| Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. | Q33690319 | ||
| Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. | Q34536660 | ||
| Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor | Q34548751 | ||
| Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis | Q34558240 | ||
| Mitogen-activated protein kinases in cell-cycle control | Q36294744 | ||
| Transgenic Gαq overexpression induces cardiac contractile failure in mice | Q36302328 | ||
| The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex | Q37273521 | ||
| Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1 and -2. | Q40503317 | ||
| Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by beta-arrestins 1 and 2. | Q40601346 | ||
| Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry | Q40976467 | ||
| Agonist-induced phosphorylation of the angiotensin II (AT(1A)) receptor requires generation of a conformation that is distinct from the inositol phosphate-signaling state | Q42482690 | ||
| Phosphorylation of elk-1 by MEK/ERK pathway is necessary for c-fos gene activation during cardiac myocyte hypertrophy. | Q43505207 | ||
| Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. | Q43843213 | ||
| Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors. | Q43922018 | ||
| Modulation of the peroxisomal gene expression pattern by dehydroepiandrosterone and vitamin D: therapeutic implications | Q44244465 | ||
| Expressions of junB and c-fos are enhanced in 4-nitroquinoline 1-oxide-induced rat tongue cancers. | Q44692916 | ||
| Beta-arrestin 2 regulates zebrafish development through the hedgehog signaling pathway | Q47073322 | ||
| The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation | Q50335944 | ||
| Cyclin D2 induces proliferation of cardiac myocytes and represses hypertrophy. | Q54792697 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 296-301 | |
| P577 | publication date | 2007-05-01 | |
| P1433 | published in | Basic and Clinical Pharmacology and Toxicology | Q15724438 |
| P1476 | title | Differential extracellular signal-regulated kinases 1 and 2 activation by the angiotensin type 1 receptor supports distinct phenotypes of cardiac myocytes | |
| P478 | volume | 100 |
| Q35796567 | Angiotensin II Type 1 Receptor-Mediated Electrical Remodeling in Mouse Cardiac Myocytes |
| Q35216489 | Angiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts and myocytes |
| Q38209177 | Apelin receptor: its responsiveness to stretch mechanisms and its potential for cardiovascular therapy |
| Q34249203 | Arrestin-dependent angiotensin AT1 receptor signaling regulates Akt and mTor-mediated protein synthesis. |
| Q33890802 | Beyond desensitization: physiological relevance of arrestin-dependent signaling. |
| Q28476374 | Biased Signaling of the Angiotensin II Type 1 Receptor Can Be Mediated through Distinct Mechanisms |
| Q27324330 | Cardiomyocyte-specific expression of lamin a improves cardiac function in Lmna-/- mice |
| Q51865105 | Cell-specific detection of microRNA expression during cardiomyogenesis by combined in situ hybridization and immunohistochemistry |
| Q37232104 | Current and future G protein-coupled receptor signaling targets for heart failure therapy |
| Q37550019 | Diversity in arrestin function |
| Q46960983 | Emergent biological properties of arrestin pathway-selective biased agonism |
| Q35999789 | Fulfilling the Promise of "Biased" G Protein-Coupled Receptor Agonism. |
| Q36446506 | Functional monoclonal antibody acts as a biased agonist by inducing internalization of metabotropic glutamate receptor 7 |
| Q37898924 | G Protein–Dependent and G Protein–Independent Signaling Pathways and Their Impact on Cardiac Function |
| Q38090168 | GPCR biased ligands as novel heart failure therapeutics |
| Q35660111 | GRK2 and β-arrestins in cardiovascular disease: Something old, something new |
| Q36241932 | International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected]. |
| Q42806160 | Lack of evidence for AT1R/B2R heterodimerization in COS-7, HEK293, and NIH3T3 cells: how common is the AT1R/B2R heterodimer? |
| Q37610141 | Minireview: More than just a hammer: ligand "bias" and pharmaceutical discovery. |
| Q37291841 | Molecular determinants of angiotensin II type 1 receptor functional selectivity |
| Q64103540 | Not all arrestins are created equal: Therapeutic implications of the functional diversity of the β-arrestins in the heart |
| Q37431141 | Overexpression of SerpinE2/protease nexin-1 Contribute to Pathological Cardiac Fibrosis via increasing Collagen Deposition |
| Q28304837 | Physiologic and cardiac roles of beta-arrestins |
| Q30002306 | Predicting Kinase Activity in Angiotensin Receptor Phosphoproteomes Based on Sequence-Motifs and Interactions |
| Q52667266 | Purinergic P2Y6 receptors heterodimerize with angiotensin AT1 receptors to promote angiotensin II-induced hypertension |
| Q34122067 | Quantitative phosphoproteomics dissection of seven-transmembrane receptor signaling using full and biased agonists |
| Q38221447 | Steroidogenesis-adrenal cell signal transduction |
| Q39381430 | The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling |
| Q92857357 | The Role of β-Arrestin Proteins in Organization of Signaling and Regulation of the AT1 Angiotensin Receptor |
| Q33594749 | The impact of ANG II and IV on INS-1 cells and on blood glucose and plasma insulin |
| Q37980266 | Therapeutic Potential of Functional Selectivity in the Treatment of Heart Failure |
| Q36773331 | Therapeutic potential of β-arrestin- and G protein-biased agonists. |
| Q47404822 | [Sar1, Ile4, Ile8]-angiotensin II Potentiates Insulin Receptor Signalling and Glycogen Synthesis in Hepatocytes |
| Q38713058 | β-Arrestin-biased AT1R stimulation promotes extracellular matrix synthesis in renal fibrosis |
| Q37421052 | βArrestins in cardiac G protein-coupled receptor signaling and function: partners in crime or "good cop, bad cop"? |
Search more.